0001225208-24-001900.txt : 20240212
0001225208-24-001900.hdr.sgml : 20240212
20240212192522
ACCESSION NUMBER: 0001225208-24-001900
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taubert Jennifer L
CENTRAL INDEX KEY: 0001745938
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24622075
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0508
4
2024-02-08
0000200406
JOHNSON & JOHNSON
JNJ
0001745938
Taubert Jennifer L
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
EVP, WW Chair, Pharmaceuticals
0
Common Stock
2024-02-08
4
M
0
3739.0000
0.0000
A
143329.0010
D
Common Stock
2024-02-08
4
F
0
1913.0000
156.3300
D
141416.0010
D
Common Stock
2024-02-09
4
M
0
59397.0000
90.4400
A
200813.0010
D
Common Stock
2024-02-09
4
S
0
59397.0000
156.2700
D
141416.0010
D
Restricted Share Units
2024-02-08
4
M
0
3739.0000
0.0000
D
2024-02-08
Common Stock
3739.0000
0.0000
D
Employee Stock Options (Right to Buy)
90.4400
2024-02-09
4
M
0
59397.0000
0.0000
D
2017-02-11
2024-02-09
Common Stock
59397.0000
0.0000
D
Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
Shares withheld for payment of taxes upon vesting of Restricted Share Units.
This transaction was executed in multiple trades at prices ranging from $156.180 to $156.360. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Raavi K. Deol, as attorney-in-fact for Jennifer Taubert
2024-02-12